Digital Symptom Tracking and Wellness in Long COVID Patients Using Endourage Targeted Wellness Formula C™ Sublingual Drops
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Endourage, LLC
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Symptom and wellbeing change over 3 months
Study Overview
Brief Summary
This is a digital symptom tracking study of Formula C™, a full cannabis flower formulation, rich in cannabinoids and terpenes, that has been shown to improve symptoms in people with Long COVID. Participants 21 and older will take Formula C™ for 90 days. During that time, participants will answer weekly surveys to track symptoms and wellbeing.
Detailed Description
Long COVID is a global health crisis with no current treatments. There's a growing interest within the medical community to explore the potential benefits of full hemp flower extracts in treating and alleviating Long COVID symptoms. Full hemp flower extracts are a remarkable advancement in the field of natural wellness and healing. Full hemp flower extracts harness the full spectrum of beneficial compounds present in the hemp plant, including not just cannabidiol (CBD), but a host of other cannabinoids, terpenes, and flavonoids. This process, known as 'whole plant' or 'full spectrum' extraction, produces a more potent and therapeutic product, as the various compounds work synergistically in what is referred to as the 'entourage effect'. These extracts have been associated with a broad range of potential health benefits, such as pain relief, reduction of inflammation, anxiety management, and sleep improvement. A recently published single-blind, randomized, placebo controlled trial demonstrated that Long COVID patients benefitted from sublingual use of Formula C without any safety events. This remote, observational study of Endourage Targeted Wellness Formula C™ sublingual drops will seek to empower participants to track symptoms and wellbeing while taking Formula C to determine if Long COVID symptoms are attenuated and time to healing is shortened.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 21 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Must be at least 21 years of age.
- •Willing and able to read, understand, and sign the informed consent.
- •Willing to comply with all study procedures.
- •Must have device to access the internet to complete surveys online.
- •A diagnosis of Long COVID from a health care provider.
Exclusion Criteria
- •Non-English speaking, as the surveys are developed in the English language.
- •Known allergies to hemp seeds or hemp-derived products, medical cannabis, coconut oil.
- •Pregnancy, or planning to become pregnant in the next 3 months
Outcomes
Primary Outcomes
Symptom and wellbeing change over 3 months
Time Frame: 90 days
This study will use the PROMIS-29+2 Profile v2.1 (PROPr) is used to calculate a change in Long COVID related symptoms including fatigue, sleep, pain, mood and physical function.
Secondary Outcomes
- Patient Global Impression of Change(90 days)